Study details
Enrolling now
Progesterone to Prevent Postpartum Smoking Relapse
University of Minnesota
NCT IDNCT04783857ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
279
Study length
about 4.1 years
Ages
18–45
Sex
Female only
Locations
1 site in MN
What this study is about
Researchers are testing if taking progesterone can help women who smoke after giving birth not relapse and reduce the risk of smoking. The trial will also look at how this affects babies' health, as well as differences in outcomes based on race or ethnicity.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Progesterone 200 MG Oral Capsule
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
progesterone (Progestin hormone; prepares uterus lining)
Drug routes
oral (Oral Capsule)